17-BMP |
beclomethasone 17-monopropionate |
ACA |
Affordable Care Act |
ADAP |
AIDS Drug Assistance Program |
Ag/Ab |
antigen/antibody |
Al |
aluminum |
ALT |
alanine aminotransferase |
AMP |
average manufacturer price |
ART |
antiretroviral therapy |
ARTAS |
Anti-Retroviral Treatment and Access to Services |
ARV |
antiretroviral |
ASP |
average sales price |
AST |
aspartate aminotransferase |
AUC |
area under the curve |
AUD |
alcohol use disorder |
AUDIT-C |
Alcohol Use Disorders Identification Test-Consumption |
AV |
atrioventricular |
AWP |
average wholesale price |
AYA |
adolescents and young adults |
BMD |
bone mineral density |
BUN |
blood urea nitrogen |
Ca |
calcium |
CaCO3 |
calcium carbonate |
CBC |
complete blood count |
CCB |
calcium channel blockers |
CD4 |
CD4 T lymphocyte |
CDC |
Centers for Disease Control and Prevention |
CHF |
congestive heart failure |
CI |
confidence interval, capsid inhibitor |
CKD |
chronic kidney disease |
Cl |
chloride |
Cmax |
maximum plasma concentration |
Cmin |
minimum plasma concentration |
CMV |
cytomegalovirus |
CNS |
central nervous system |
COC |
combined oral contraceptive |
CPI-U |
consumer price index-urban |
CPK |
creatine phosphokinase |
Cr |
creatinine |
CrCl |
creatinine clearance |
CSF |
cerebrospinal fluid |
CV |
cardiovascular |
CVD |
cardiovascular disease |
CYP |
cytochrome P450 |
D/M |
dual/mixed |
DAA |
direct-acting antiviral |
DHA |
dihydroartemisinin |
DILI |
drug-induced liver injury |
DM |
diabetes mellitus |
DMPA |
depot medroxyprogesterone acetate |
DOT |
directly observed therapy |
EBV |
Epstein-Barr virus |
ECG |
electrocardiogram |
eGFR |
estimated glomerular filtration rate |
ESRD |
end stage renal disease |
FCP |
federal price ceiling |
FDA |
U.S. Food and Drug Administration |
FDC |
fixed-dose combination |
Fe |
iron |
FUL |
federal upper limit |
GAHT |
gender-affirming hormone therapy |
GHB |
gamma-hydroxybutyrate |
GI |
gastrointestinal |
gp |
glycoprotein |
GS |
Gilead Sciences |
H2 |
histamine 2 |
H2RA |
H2 receptor antagonist |
HAD |
HIV-associated dementia |
HAND |
HIV-associated neurocognitive disorder |
HAV |
hepatitis A virus |
HbA1C |
hemoglobin A1c |
HBcAb |
hepatitis B core antibody |
HBeAg |
hepatitis B e antigen |
HBsAb |
hepatitis B surface antibody |
HBsAg |
hepatitis B surface antigen |
HBV |
hepatitis B virus |
HCC |
hepatocellular carcinoma |
HCO3 |
bicarbonate |
HCV |
hepatitis C virus |
HD |
hemodialysis |
HDL |
high-density lipoprotein |
HHS |
U.S. Department of Health and Human Services |
HIV |
human immunodeficiency virus |
HIV RNA |
HIV viral load |
HIV-1 |
human immunodeficiency virus type 1 |
HIV-2 |
human immunodeficiency virus type 2 |
HIVMA/IDSA |
HIV Medicine Association of the Infectious Diseases Society of America |
HLA |
human leukocyte antigen |
HMG-CoA |
hydroxy-methylglutaryl-coenzyme A |
HR |
hazard ratio |
HRSA |
Health Resources and Services Administration |
HRT |
hormone replacement therapy |
hs-CRP |
high-sensitivity C-reactive protein |
HSR |
hypersensitivity reaction |
HTLV-1 |
human T-lymphotropic virus-1 type I |
IAS–USA |
International AIDS Society–USA |
IC50 |
inhibitory concentration |
IL |
interleukin |
IM |
intramuscular |
IN |
integrase |
INR |
international normalized ratio |
INSTI |
integrase strand transfer inhibitor |
IPT |
isoniazid preventive therapy |
IRIS |
immune reconstitution inflammatory syndrome |
ISR |
injection site reactions |
IUD |
intrauterine device |
IV |
intravenous |
K |
potassium |
LA-ART |
long-acting ART |
LAI |
long-acting injectable |
LDL |
low-density lipoprotein |
LGBTQ |
lesbian, gay, bisexual, transgender, or queer |
LLOD |
lower limits of detection |
LTBI |
latent tuberculosis infection |
MAC |
Mycobacterium avium complex |
MAT |
medication-assisted treatment |
MATE |
multidrug and toxin extrusion transporter |
MDR |
multidrug resistant |
MDR-TB |
multidrug-resistant tuberculosis |
MDMA |
methylenedioxymethamphetamine |
MDRP |
Medicaid Drug Rebate Program |
MET |
motivational enhancement therapy |
Mg |
magnesium |
MHC |
major histocompatibility complex |
MI |
motivational interviewing |
MI |
myocardial infarction |
MPA |
medroxyprogesterone acetate |
MRI |
magnetic resonance imaging |
MSM |
men who have sex with men |
MTR |
multi-tablet regimen |
N/A |
not applicable |
Na |
sodium |
NA-ACCORD |
North American AIDS Cohort Collaboration on Research and Design |
NIH |
National Institutes of Health |
NNRTI |
non-nucleoside reverse transcriptase inhibitor |
NRTI |
nucleoside/nucleotide reverse transcriptase inhibitor |
NTD |
neural tube defect |
OARAC |
Office of AIDS Research Advisory Council |
OAT |
opioid agonist therapy |
OATP |
organic anion-transporting polypeptide |
OBR |
optimized background regimen |
OCT2 |
organic cation transporter 2 |
OH-itraconazole |
active metabolite of itraconazole |
OI |
opportunistic infection |
ONDCP |
Office of National Drug Control Policy |
OR |
odds ratio |
OTP |
opioid treatment program |
OUD |
opioid use disorder |
P |
phosphorus |
P-gp |
p-glycoprotein |
PAH |
pulmonary arterial hypertension |
PBM |
pharmacy benefit manager |
PCP |
Pneumocystis jirovecii pneumonia |
PCR |
polymerase chain reaction |
PDE5 |
phosphodiesterase type 5 |
PHQ-2 |
Patient Health Questionnaire-2 |
PEP |
post-exposure prophylaxis |
PI |
protease inhibitor |
PI/c |
cobicistat-boosted protease inhibitor |
PI/r |
ritonavir-boosted protease inhibitor |
PK |
pharmacokinetic |
PO |
orally |
PPI |
proton pump inhibitor |
PR |
protease |
PrEP |
pre-exposure prophylaxis |
PTH |
parathyroid hormone |
QTc |
QT corrected for heart rate |
REPC |
Retention through Enhanced Personal Contact |
RNA |
ribonucleic acid |
RT |
reverse transcriptase |
RWHAP |
Ryan White HIV/AIDS Program |
SAMHSA |
Substance Abuse and Mental Health Services Administration |
SCr |
serum creatinine |
SJS |
Stevens Johnson Syndrome |
SMAC |
state maximum allowable cost |
SMR |
sexual maturity rating |
SPT |
skin patch test |
SQ |
subcutaneous |
SSRI |
selective serotonin reuptake inhibitor |
STI |
sexually transmitted infection |
STR |
single-tablet regimen |
SUD |
substance use disorder |
TasP |
treatment as prevention |
TB |
tuberculosis |
TC |
total cholesterol |
TCA |
tricyclic antidepressant |
TDM |
therapeutic drug monitoring |
TDR |
transmitted drug resistance |
TG |
triglyceride |
The Panel |
The Panel on Antiretroviral Guidelines for Adults and Adolescents |
THRIVE |
Targeting HIV Retention and Improved Viral load through Engagement |
U = U |
Undetectable = Untransmittable |
UGT |
uridine diphosphate glucuronosyltransferase |
UGT1 |
uridine diphosphate glucuronyltransferase 1 family |
UGT1A1 |
uridine diphosphate glucuronosyltransferase 1A1 |
ULN |
upper limit of normal |
USTS |
U.S. Transgender Survey |
UW |
University of Washington |
VL |
viral load |
VPA |
valproic acid |
WAC |
wholesale acquisition cost |
WBC |
white blood cell |
WHO |
World Health Organization |
WPATH |
World Professional Association for Transgender Health |
XDR |
extensively drug resistant |
XR |
extended release |
Zn |
zinc |